Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

L-Dopa Modulated Striatal Functional Connectivity in Schizotypal Adults: a Randomized Double-blind Placebo-controlled Study

NCT03333369 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT03333369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03333369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
L-Dopa Modulated Striatal Functional Connectivity in Schizotypal Adults: a Randomized Double-blind Placebo-controlled Study
Lead sponsor
University of Zurich
Phase
Phase 1
Overall status
Completed
Start date
May 15, 2014
Completion date
August 13, 2015
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, schizotypal personality